| |
| |
 |
Diesen Newsletter in Deutsch anzeigen.
Nächsten Newsletter in Deutsch erhalten? Antworten Sie uns bitte mit "Sprache wechseln".
|
| |
 |
|
Business Association Chemistry Pharma Biotech |
|
| |
Newsletter
January 16th, 2015
|
|
|
To whom it may concern
scienceindustries, the Swiss Business Association Chemistry Pharma Biotech, keeps you informed about our industry‘s standpoints on current politico-economic and social topics. |
| |
|
|
Swiss National Bank poses major challenges to export industry
The surprise decision of the Swiss National Bank to discontinue the minimum exchange rate of CHF 1.20 per Euro poses major challenges to Switzerland‘s largest export industry Chemistry Pharma Biotech.
Although the extent of the strengthening of the Swiss franc against other major currencies is still uncertain, the measure will without any doubt have a negative impact on the price competitiveness of our exports. Not only will this dim the growth prospects, but it may also lead to structural adjustments in the companies of our industry. We hope the Swiss National Bank will prevent an excessive strengthening of the Swiss franc. Against this new background, additional burdens on the economy in the form of new regulation projects, such as for example the Energy Strategy 2050, should be avoided by all means. |
| |
|
|
What is the significance of the bilateral agreements for Chemistry Pharma Biotech?
Experts in scienceindustries‘ member companies analyse Switzerland‘s existing bilateral agreements with the European Union in the Fact Sheet on «The core content for industry of the bilateral agreements». The results show the core content for industry of these agreements from the point of view of Chemistry Pharma Biotech, the largest export industry in Switzerland. |
| |
|
|
Implementation of the «Mass immigration initiative»
The long-term goal for industry in European policy is to ensure sufficient immigration of highly-qualified specialist staff from all over the world, and to retain the bilateral agreement with the EU. On 8th January 2015, scienceindustries and its partner organisations economiesuisse, Swiss Employers Organisation and Swissmem presented the «Industry strategy for the implementation of the Mass immigration initiative» at a media conference. The conceptual point of departure for this strategy is the temporary restriction on the movement of persons by a protective clause. The publication of the Federal consultation draft for the implementation of the «Mass immigration initiative» is expected shortly.
|
| |
|
|
Counterproposal on «Green economy» - demands from scienceindustries largely met for the revision of the law on environmental protection
In the 2014 autumn session, the Swiss Council of States resolved upon the revision of the law on environmental protection under clearly defined directives. These include taking account of the critical points from the consultation draft and the restriction to measures with a positive cost/benefit ratio. Furthermore, the section on "Consumption and protection" is to be restricted to particularly critical raw materials. In the 2014 winter session, the Council of States agreed by a majority to this revised version of the indirect counterproposal. This means that some important demands by scienceindustries have been fulfilled. For example, the reduction of environmental pollution originating abroad is not to be included in the law. The duty to inform consumers about the environmental effects of products and to introduce product traceability is also removed. Restrictions are still possible with regard to bringing products into circulation, but only on an individual basis, and they can only be required if recognised international standards apply to these products. In January 2015, the commission of the Swiss National Council begins its consultation. scienceindustries will make every effort to define the term "international standards" in greater detail.
|
| |
|
|
Swiss National Council wants to start up expensive subsidy machinery for «Energy strategy 2050»
The revised Pharma Code now includes a ban on gifts, which came into effect on 1st July 2014. On this basis, signatory companies may no longer make gifts to specialist personnel or healthcare organisations. A period of transition applies to Switzerland until 30th June 2015, during which auxiliary products of modest value and writing pads and implements bearing company logos may be handed out at events. After this period, only writing pads and implements bearing no logos will still be permitted at events.
|
| |
|
|
Company tax reform USR III: "Yes" to the introduction of a broad licence box and the direct promotion of investment into research and development
In the case of USR III, scienceindustries supports in particular the introduction of a broad licence box (not just patents) as a key replacement measure for the Cantonal tax regime now to be abolished. In addition, we also anticipate the direct promotion of investment into research and development. In order to ensure the success of USR III, the reform must focus on its main task, the retention or reinforcement of the competitiveness of Switzerland with regard to tax. It is therefore essential that we avoid the introduction of a tax on capital gains.
|
| |
|
|
New position paper on «Hormone-active substances»
scienceindustries has created two new working groups in the areas of «Nutrition» and «Industrial Biotechnology». Various member companies of scienceindustries with an interest in these subjects have already confirmed their collaboration. The new working groups are intended to ensure the flow of information in both sectors and to launch targeted activities. Any interested member companies should register with the scienceindustries office.
|
| |
|
|
GMO: Food labelling – «Manufactured without genetic technology»: strict requirements retained
scienceindustries is committed to the clear and transparent labelling of foods. In our Statement on the proposed revision to the Swiss Ordinance on foods altered by genetic technology, we rejected any deviation from the previous strict requirements for the «manufactured without genetic technology» label. We therefore welcome the decision of the Federal Department of Home Affairs in December 2014 to retain the current strict and unambiguous ruling of the Regulation on genetically modified food for a negative GMO declaration.
|
| |
|
|
New scienceindustries working groups on «Nutrition» and «Industrial Biotechnology»
scienceindustries has created two new working groups in the areas of «Nutrition» and «Industrial Biotechnology». Various member companies of scienceindustries with an interest in these subjects have already confirmed their collaboration. The new working groups are intended to ensure the flow of information in both sectors and to launch targeted activities. Any interested member companies should register with the scienceindustries office.
|
| |
|
|
Welcome to scienceindustries! New member companies in 2014
scienceindustries welcomes the following companies who joined the existing 250 member companies of our association. Your membership will strengthen the efforts of scienceindustries to enhance the development of Switzerland as a leading international location for our industry.
AROVET AG, 8953 Dietikon
Biokema SA, 1023 Crissier
Dr. E. Graeub AG, 3018 Bern
Eisai Pharma AG, 8052 Zürich
Otsuka Pharmaceutical (Switzerland) GmbH, 8152 Glattbrugg
Provet AG, 3421 Lyssach b. Burgdorf
Streuli Pharma AG, 8730 Uznach
ufamed AG, 6210 Sursee
Vital AG, 5036 Oberentfelden
Werner Stricker AG, 3052 Zollikofen
|
| |
|
|
Follow scienceindustries on Facebook and Twitter
Keep informed about Switzerland as a location for research and production and follow your industry‘s association on Facebook and Twitter.
|
| |
|
|
Would you like to know more about our perspectives, or would you like to ask us some questions? If so, please contact our specialist staff at scienceindustries.
|
sig. Dr. Beat Moser
Director |
sig. Marcel Sennhauser
Head of Communications |
|
|
|
|
|
